Catalent Pharma Solutions Appoints Key Executive to Dual Role
Will Downie enters into the dual role of group president, Sterile Technologies, and senior VP, Global Sales and Marketing, at Catalent Pharma Solutions Inc. (Somerset, N.J.), effective Oct. 12, 2009. Mr. Downie will have full accountability for the Sterile Technologies segment, which includes the company's injectable manufacturing businesses in Brussels, Belgium, and Limoges, France, as well as its blow-fill-seal business, based in Woodstock, Ill.
Mr. Downie will lead the global sales and marketing functions, including Catalent's global account sales team. Mr. Downie will report to John Chiminski, president and CEO, Catalent, and will be based in Catalent's Swindon, U.K. office.
“I am pleased to welcome Will to the Catalent executive team," says John Chiminski, president and CEO, Catalent (www.catalent.com). "I've worked with him for a number of years, and I believe Will's unique combination of business management experience and sales and marketing expertise will help us accelerate organic growth for both our Sterile business and the Company overall.”
Mr. Downie was VP and global leader of the Molecular Imaging business at GE Healthcare (Waukesha, Wis.), where he was responsible for leading a global organization of 1,800 people, with five manufacturing sites and revenues of about 650 million annually. Before this, his positions at GE Healthcare included VP and general manager of Medical Diagnostics in Europe, the Middle East and Africa; VP and general manager, Europe; and VP, sales for Medical Diagnostics in Europe. Before GE Healthcare, Mr. Downie held senior management positions in operations, sales and marketing at Innovex UK Ltd., a contract sales division of Quintiles (Raleigh-Durham, N.C.). Mr. Downie also held commercial leadership positions with Sanofi-Synthelabo UK, Sanofi-Winthrop Ltd., and Merck.
Catalent Pharma Solutions provides advanced technologies, and development, manufacturing, and packaging services for pharmaceutical, biotechnology, and consumer healthcare companies in about 100 countries.